{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:16:30Z","timestamp":1784945790553,"version":"3.55.0"},"reference-count":64,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2002,5,28]],"date-time":"2002-05-28T00:00:00Z","timestamp":1022544000000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2002,5]]},"abstract":"<jats:p>Glaucoma can be considered a disease of the aging eye. Most medications used to treat glaucoma are in topical eyedrop form and may cause numerous untoward systemic effects in older persons. In recent years, several new ocular hypotensive medications have become available. These medications are being used more commonly because there is a growing trend by ophthalmologists to aggressively lower intraocular pressure. Therefore, geriatricians require a comprehensive knowledge of medications used to treat glaucoma, in addition to an understanding of their mechanism of action profiles of untoward effects and possible interactions with other diseases or medications. Therefore, we performed a review of the medications recently introduced into clinical practice.<\/jats:p>\n                  <jats:p>We selected drugs approved by the U.S. Food and Drug Administration between 1996 and September 2001. The safety profiles of these agents and their untoward side effects were reviewed by class: topical carbonic anhydrase inhibitors (brinzolamide: ocular tolerance, taste perversion), \u03b2\u2010adrenoceptor antagonists (timolol: bradycardia and bronchospasm), \u03b1\u2010adrenergic agonists (brimonidine: oral dryness, headache, and fatigue), and prostaglandin analogs (latanoprost, bimatoprost, travoprost, and unoprostone isopropyl: ocular hyperemia, iris color changes).<\/jats:p>\n                  <jats:p>\n                    The function of this review is to make geriatricians more aware of the efficacy and untoward effects of medications recently introduced into clinical practice. We recommend that geriatricians perform a medication review on\n                    <jats:italic>all<\/jats:italic>\n                    medications their patients use, including eye drops.\n                  <\/jats:p>","DOI":"10.1046\/j.1532-5415.2002.50226.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T00:37:24Z","timestamp":1047429444000},"page":"956-962","source":"Crossref","is-referenced-by-count":44,"title":["New Glaucoma Medications in the Geriatric Population: Efficacy and Safety"],"prefix":"10.1111","volume":"50","author":[{"given":"Gary D.","family":"Novack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. William","family":"Molloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,5,28]]},"reference":[{"key":"e_1_2_12_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.2.264"},{"key":"e_1_2_12_3_2","first-page":"933","article-title":"Prevalence of age\u2010related maculopathy.","volume":"99","author":"Klein R","year":"1992","journal-title":"The Beaver Dam Eye Study. Ophthalmology"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)91133-2"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)72062-8"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000027415"},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00538-9"},{"key":"e_1_2_12_8_2","first-page":"685","volume-title":"Goodman & Gilman's: The Pharmacological Basis of Therapeutics","author":"Jackson EK","year":"1996"},{"key":"e_1_2_12_9_2","first-page":"730","article-title":"The pharmacology of methazolamide in relation to the treatment of glaucoma.","volume":"16","author":"Maren TH","year":"1977","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.430100407"},{"key":"e_1_2_12_11_2","unstructured":"Diamox [package insert]. Pearl River NY: Lederle Pharmaceutical 2001."},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00624-3"},{"key":"e_1_2_12_13_2","first-page":"143","article-title":"The respiratory function of the aqueous.","volume":"31","author":"Friedenwald JS","year":"1933","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(96)80042-7"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100080061030"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00196861"},{"key":"e_1_2_12_17_2","first-page":"1621","article-title":"Population pharmacokinetics of 2% topical dorzolamide in the aqueous humor of humans.","volume":"40","author":"Schmitz K","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30509-5"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(99)00179-8"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(99)00110-1"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(99)00343-8"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(99)00106-X"},{"key":"e_1_2_12_23_2","unstructured":"Trusopt [package insert]. Whitehouse Station NJ: Merck & Co. 2001."},{"key":"e_1_2_12_24_2","unstructured":"Azopt [package insert]. Fort Worth TX: Alcon Labs 2001."},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)83063-5"},{"key":"e_1_2_12_26_2","first-page":"S559","article-title":"The ocular comfort of t.i.d.\u2010dosed brinzolamide 1% compared to t.i.d.\u2010dosed dorzolamide 2% in patients with primary open\u2010angle glaucoma or ocular hypertension.","volume":"38","author":"Stewart R","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(99)00111-3"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.129.6.513"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.64.2.137"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(86)90939-6"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(87)90116-0"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(86)90941-4"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(86)90532-5"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.3109\/15569528709052176"},{"key":"e_1_2_12_35_2","unstructured":"Cosopt [package insert]. Whitehouse Station NJ: Merck & Co. 2001."},{"key":"e_1_2_12_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4835(84)90162-3"},{"key":"e_1_2_12_37_2","first-page":"86","article-title":"Die augendrucksenkende wirkung von pilokarpin und adrenalin\u2010dipivalat bei glaucoma simplex. Eine kontrollierte klinische studie.","volume":"175","author":"Krieglstein GK","year":"1979","journal-title":"Klin Mbl Augenheilk"},{"key":"e_1_2_12_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(91)32106-7"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1977.04450080078007"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1981.03930020082006"},{"key":"e_1_2_12_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1987.01060090063028"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1988.01060140058024"},{"key":"e_1_2_12_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(89)90111-6"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(89)90017-2"},{"key":"e_1_2_12_45_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713689008997579"},{"key":"e_1_2_12_46_2","unstructured":"Alphagan [package insert]. Irvine CA: Allergan Inc. 2001."},{"key":"e_1_2_12_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-199404000-00012"},{"key":"e_1_2_12_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(96)82030-3"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1997.01100160017002"},{"key":"e_1_2_12_50_2","first-page":"1639","article-title":"Eicosanoids as a new class of ocular hypotensive agents. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins.","volume":"28","author":"Hayashi M","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_12_51_2","unstructured":"Xalatan [package insert]. Peapack NJ: Pharmacia. 2001."},{"key":"e_1_2_12_52_2","first-page":"527","article-title":"Comparative phase III clinical trial of latanoprost and timolol in patients with elevated intraocular pressure.","volume":"23","author":"Alm A","year":"1995","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"e_1_2_12_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30407-7"},{"key":"e_1_2_12_54_2","first-page":"126","article-title":"A six\u2010month, randomized, double\u2010masked study comparing latanoprost with timolol in open\u2010angle glaucoma and ocular hypertension.","volume":"103","author":"Watson P","year":"1996","journal-title":"The Latanoprost Study Group. Ophthalmology"},{"key":"e_1_2_12_55_2","first-page":"1432","article-title":"Phase III double masked comparative study of UF\u2010021 ophthalmic solution in primary open\u2010angle glaucoma and ocular hypertention.","volume":"43","author":"Azuma I","year":"1992","journal-title":"Nippon Ganka Kiyo"},{"key":"e_1_2_12_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00943-0"},{"key":"e_1_2_12_57_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007999909113368"},{"key":"e_1_2_12_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00495-4"},{"key":"e_1_2_12_59_2","unstructured":"Rescula [package insert]. Duluth GA: Novartis Ophthalmics 2001."},{"key":"e_1_2_12_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00843-6"},{"key":"e_1_2_12_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(01)00219-3"},{"key":"e_1_2_12_62_2","unstructured":"Lumigan [package insert]. Irvine CA: Allergan Inc. 2001."},{"key":"e_1_2_12_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)01177-1"},{"key":"e_1_2_12_64_2","unstructured":"Travatan [package insert]. Fort Worth TX: Alcon Labs 2001."},{"key":"e_1_2_12_65_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1984.01040030429017"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1532-5415.2002.50226.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1532-5415.2002.50226.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:56:51Z","timestamp":1762189011000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1046\/j.1532-5415.2002.50226.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.1046\/j.1532-5415.2002.50226.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1532-5415.2002.50226.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}